Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  encorafenib
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Intermittent LGX818 and MEK162 in Treating Patients with Metastatic Melanoma Who Have BRAFV600 Mutations
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 14-000616, NCI-2014-01971, NCT02263898
Start Over